The DOI matches its Crossref record; 322 of the 322 references it cites were found in a registry or an index.
Oxidative stress in schizophrenia: An integrated approach
Open accessAbstract
Oxidative stress has been suggested to contribute to the pathophysiology of schizophrenia. In particular, oxidative damage to lipids, proteins, and DNA as observed in schizophrenia is known to impair cell viability and function, which may subsequently account for the deteriorating course of the illness. Currently available evidence points towards an alteration in the activities of enzymatic and nonenzymatic antioxidant systems in schizophrenia. In fact, experimental models have demonstrated that oxidative stress induces behavioural and molecular anomalies strikingly similar to those observed in schizophrenia. These findings suggest that oxidative stress is intimately linked to a variety of pathophysiological processes, such as inflammation, oligodendrocyte abnormalities, mitochondrial dysfunction, hypoactive N-methyl-D-aspartate receptors and the impairment of fast-spiking gamma-aminobutyric acid interneurons.[bkyb1] Such self-sustaining mechanisms may progressively worsen producing the functional and structural consequences associated with schizophrenia. Recent clinical studies have shown antioxidant treatment to be effective in ameliorating schizophrenic symptoms. Hence, identifying viable therapeutic strategies to tackle oxidative stress and the resulting physiological disturbances provide an exciting opportunity for the treatment and ultimately prevention of schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–322 of 322
Cho, K.-H., Kim, H., Rodríguez‐Iturbe, B., & Vaziri, N. D. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00126.2009 · Cited by 147
McCullumsmith, R. E., Gupta, D. S., BENEYTO, M., KREGER, E., HAROUTUNIAN, V., Davis, K. L., & Meador‐Woodruff, J. H. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.11.017 · Cited by 146
Increased Nitric Oxide Radicals in Postmortem Brain From Patients With Schizophrenia
Yao, J. K., Leonard, S. S., & Reddy, R. D. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007142 · Cited by 143
Abnormal age-related changes of plasma antioxidant proteins in schizophrenia
Yao, J. K., Reddy, R. D., & van Kammen, D. P. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(00)00230-4 · Cited by 143
McCurdy, R. D., Feron, F. P., Perry, C., Chant, D. C., McLean, D. E., Matigian, N., Hayward, N. K., McGrath, J. J., & Mackay‐Sim, A. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.10.012 · Cited by 141
Neurodevelopmental damage after prenatal infection: role of oxidative stress in the fetal brain
Lanté, F., Meunier, J., Guiramand, J., Maurice, T., Cavalier, M., de Jesus Ferreira, M.-C., Aimar, R., Cohen-Solal, C., Vignes, M., & Barbanel, G. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.01.027 · Cited by 140
Effects of NMDA Receptor Antagonists: Implications for the Pathophysiology of Schizophrenia
Krystal, J. H., Anand, A., & Moghaddam, B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.7.663 · Cited by 140
Bitanihirwe, B., Lim, M., Kelley, J., Kaneko, T., & Woo, T. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-71 · Cited by 137
Self-citationWoo, T.-U. W., Kim, A. M., & Viscidi, E. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.092 · Cited by 136
Self-citationA histochemical study of iron‐positive cells in the developing rat brain
Connor, J. R., Pavlick, G., Karli, D. C., Menzies, S. L., & Palmer, C. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903550112 · Cited by 136
Martins-de-Souza, D., Harris, L. W., Guest, P. C., & Bahn, S. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3459 · Cited by 134
Dakhale, G. N., Khanzode, S. D., Khanzode, S. S., & Saoji, A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0117-1 · Cited by 131
Tang, L. H., & Aizenman, E. (1993) · The Journal of Physiology · doi:10.1113/jphysiol.1993.sp019678 · Cited by 129
Neurobiology of Schizophrenia Spectrum Disorders: The Role of Oxidative Stress
Wood, S. J., Yücel, M., Pantelis, C., & Berk, M. (2009) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v38n5p396 · Cited by 128
Implication du stress oxydant dans la physiopathologie de la schizophrénie : revue de la literature
Fendri, C., Mechri, A., Khiari, G., Othman, A., Kerkeni, A., & Gaha, L. (2006) · L Encéphale · doi:10.1016/s0013-7006(06)76151-6 · Cited by 128
Oxidative Damage and Schizophrenia: The Potential Benefit by Atypical Antipsychotics
Dakhale, G. N., Khanzode, S. D., Khanzode, S. S., Saoji, A., Khobragade, L., & Turankar, A. V. (2004) · Neuropsychobiology · doi:10.1159/000077368 · Cited by 127
Effects of haloperidol on antioxidant defense system enzymes in schizophrenia
Yao, J. K., Reddy, R. D., McElhinny, L. G., & van Kammen, D. P. (1998) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)00028-4 · Cited by 127
Truman, J. W., de Vente, J., & Ball, E. E. (1996) · Development · doi:10.1242/dev.122.12.3949 · Cited by 125
Abnormal Glucose Metabolism in the Mediodorsal Nucleus of the Thalamus in Schizophrenia
Hazlett, E. A., Buchsbaum, M. S., Kemether, E. M., Bloom, R. F., Platholi, J., Brickman, A. M., Shihabuddin, L., Tang, C. Y., & Byne, W. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.305 · Cited by 124
Yao, J., Dougherty, G. G., Reddy, R. D., Keshavan, M. S., Montrose, D. M., Matson, W. R., Rozen, S., Krishnan, R. R., McEvoy, J. P., & Kaddurah‐Daouk, R. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.33 · Cited by 122
Reduced level of plasma antioxidant uric acid in schizophrenia
Yao, J. K., Reddy, R. D., & van Kammen, D. P. (1998) · Psychiatry Research · doi:10.1016/s0165-1781(98)00051-1 · Cited by 121
Increased mitochondrial complex I activity in platelets of schizophrenic patients
Ben‐Shachar, D., Zuk, R., Gazawi, H., Reshef, A., Sheinkman, A., & Klein, E. (1999) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145799001649 · Cited by 114
Male gender is associated with deficit schizophrenia: a meta-analysis
Roy, M., Maziade, M., Labbé, A., & Mérette, C. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00231-5 · Cited by 112
Xu, B., Wratten, N. S., Charych, E. I., Buyske, S. G., Firestein, B. L., & Brzustowicz, L. M. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020263 · Cited by 111
Homocysteine levels in newly admitted schizophrenic patients
Applebaum, J., Shimon, H., Sela, B., Belmaker, R. H., & Levine, J. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.01.003 · Cited by 110
Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia
Shinkai, T., Ohmori, O., Hori, H., & Nakamura, J. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001041 · Cited by 109
Association between Ala–9Val polymorphism of Mn-SOD gene and schizophrenia
Akyol, Ö., Yanık, M., Elyas, H., Namlı, M. N., Canatan, H., Akın, H., Yüce, H., Yilmaz, H. R., Tutkun, H., Söğüt, S., et al. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.10.014 · Cited by 107
Medial temporal lobe glutathione concentration in first episode psychosis: A 1H-MRS investigation
Wood, S. J., Berger, G. E., Wellard, R. M., Proffitt, T., McConchie, M., Berk, M., McGorry, P. D., & Pantelis, C. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.11.018 · Cited by 107
Plasma Manganese, Selenium, Zinc, Copper, and Iron Concentrations in Patients with Schizophrenia
Yanık, M., Koçyiğit, A., Tutkun, H., Vural, H., & Herken, H. (2004) · Biological Trace Element Research · doi:10.1385/bter:98:2:109 · Cited by 106
Free radical mechanisms in schizophrenia and tardive dyskinesia
Cadet, J. L., & Kahler, L. A. (1994) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)90001-9 · Cited by 106
Increased Levels of Nitric Oxide, Cortisol and Adrenomedullin in Patients with Chronic Schizophrenia
Yılmaz, N., Herken, H., Ciçek, H. K., Çelik, A., Yürekli, M., & Akyol, Ö. (2007) · Medical Principles and Practice · doi:10.1159/000098367 · Cited by 102
Modulation of glutamate receptor functions by glutathione
Oja, S. S., Janáky, R., Varga, V., & Saransaari, P. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(00)00031-0 · Cited by 102
Evaluation of antioxidant deficit in schizophrenia
Sharma, P., Dadheech, G., Mishra, S., & Gautam, S. (2008) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.39753 · Cited by 101
A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress
Marchbanks, R. M., Ryan, M., Day, I. N. M., Owen, M., McGuffin, P., & Whatley, S. A. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00011-2 · Cited by 101
Dean, O. M., van den Buuse, M., Bush, A. I., Copolov, D., Ng, F., Dodd, S., & Berk, M. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788803060 · Cited by 101
Tamminga, C. A. (1997) · PubMed · Cited by 100
Bowers, M. B. (1973) · Psychopharmacology · doi:10.1007/bf00422751 · Cited by 99
Nitrite content and antioxidant enzyme levels in the blood of schizophrenia patients
Srivastava, N., Barthwal, M. K., Dalal, P., Agarwal, A. K., Nag, D., Srimal, R. C., Seth, P. K., & Dikshit, M. (2001) · Psychopharmacology · doi:10.1007/s002130100860 · Cited by 99
Sorce, S., Schiavone, S., Tucci, P., Colaianna, M., Jaquet, V., Cuomo, V., Dubois‐Dauphin, M., Trabace, L., & Krause, K. H. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1491-10.2010 · Cited by 98
Terpstra, M., Vaughan, T. J., Uǧurbil, K., Lim, K. O., Schulz, S. C., & Rolf Gruetter, A. (2005) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-005-0012-0 · Cited by 98
Gamma oscillation deficits and the onset and early progression of schizophrenia
Woo, T.-U. W., Spencer, K., & McCarley, R. W. (2010) · Harvard Review of Psychiatry · doi:10.3109/10673221003747609 · Cited by 96
Self-citationCraddock, R. M., Lockstone, H. E., Rider, D. A., Wayland, M. T., Harris, L. W., McKenna, P. J., & Bahn, S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000692 · Cited by 95
Cabungcal, J.-H., Preissmann, D., Delseth, C., Cuénod, M., Kim, Q., & Schenk, F. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.03.001 · Cited by 94
Regionally Diverse Cortical Pathology in Schizophrenia: Clues to the Etiology of the Disease
Selemon, L. D. (2001) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006881 · Cited by 94
Zinc, Manganese, Calcium, Copper, and Cadmium Level in Scalp Hair Samples of Schizophrenic Patients
Rahman, M. A., Azad, M. A. K., Hossain, M. I., Qusar, M. S., Bari, W., Begum, F., Huq, S. M. I., & Hasnat, A. (2008) · Biological Trace Element Research · doi:10.1007/s12011-008-8230-8 · Cited by 93
Connor, J. R. (2007) · Developmental Neuroscience · doi:10.1159/000112115 · Cited by 91
Zhang, X. Y., Zhou, D. F., Zhang, P. Y., Wu, G. Y., Su, J. M., & Cao, L. Y. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1107 · Cited by 90
Sharp, F. R., Butman, M., Koıstınaho, J., Aardalen, K., Näkki, R., Massa, S. M., Swanson, R. A., & Sagar, S. M. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90345-x · Cited by 89
Smythies, J. (1999) · Neurotoxicity Research · doi:10.1007/bf03033337 · Cited by 88
Redox regulation of cellular stress response in neurodegenerative disorders.
Calabrese, V., Guagliano, E., Sapienza, M. A., Mancuso, C., Butterfield, D. A., & Stella, A. M. G. (2006) · PubMed · Cited by 87
Antioxidant properties of propofol and erythropoietin after closed head injury in rats
Öztürk, E., Demirbilek, S. G., But, A., Sarıçiçek, V., Güleç, M., Akyol, Ö., & Ersoy, M. Ö. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.04.028 · Cited by 86
Sperner‐Unterweger, B., Whitworth, A. B., Kemmler, G., Hilbe, W., Thaler, J., Weiß, G., & Fleischhacker, W. W. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00175-3 · Cited by 86
Nitric Oxide Signaling and Nitrosative Stress in Neurons: Role for S -Nitrosylation
Shahani, N., & Sawa, A. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3580 · Cited by 86
Castellani, R. J., Smith, M. A., Nunomura, A., Harris, P. L. R., & Perry, G. L. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00016-7 · Cited by 85
Influence of Gender in Schizophrenia as Related to Other Psychopathological Syndromes
Flor-Henry, P. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.2.211 · Cited by 85
Johansson, C., Jackson, D. M., & Svensson, L. (1997) · Psychopharmacology · doi:10.1007/s002130050280 · Cited by 82
The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients
Zhang, X., Chen, D. C., Xiu, M. H., Wang, F., Qi, L. Y., Sun, H. Q., Chen, S., He, S. C., Wu, G. Y., Haile, C. N., et al. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.05.016 · Cited by 82
Yuan, X., Brunk, U. T., & OLSSON, A. G. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.9.1345 · Cited by 80
Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice
Dean, O. M., Bush, A. I., Berk, M., Copolov, D., & van den Buuse, M. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.11.017 · Cited by 80
Magnetic Resonance Spectroscopy Study of the Antioxidant Defense System in Schizophrenia
Matsuzawa, D., & Hashimoto, K. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3453 · Cited by 79
H2O2-induced higher order chromatin degradation: A novel mechanism of oxidative genotoxicity
Konat, G. W. (2003) · Journal of Biosciences · doi:10.1007/bf02970132 · Cited by 79
McCreadie, R. G., MacDonald, E., Wiles, D. H., Campbell, G. R., & Paterson, J. R. (1995) · The British Journal of Psychiatry · doi:10.1192/bjp.167.5.610 · Cited by 78
Nitric oxide synthase (NOS) in schizophrenia
Karson, C. N., Griffin, W. S. T., Mrak, R. E., Husain, M., Dawson, T. M., Snyder, S. H., Moore, N. C., & Sturner, W. Q. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815109 · Cited by 76
Radonjić, N. V., Knežević, I. D., Vilimanovich, U., Kravić-Stevović, T., Marina, L. V., Nikolić, T., Todorović, V., Bumbaširević, V., & Petronijević, N. D. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.12.009 · Cited by 75
Singh, O., Chakraborty, I., Dasgupta, A., & Datta, S. (2008) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.43627 · Cited by 74
Xi, D., Keeler, B. E., Zhang, W., Houlé, J. D., & Gao, W. (2008) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.09.013 · Cited by 74
Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia
Bulut, M., Savas, H. A., Altindag, A., Virit, O., & Dalkilic, A. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970903144004 · Cited by 73
Aguilar-Valles, A., Flores, C., & Luheshi, G. N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010967 · Cited by 72
Vitamin C status in chronic schizophrenia
Subotičanec, K., Folnegović-Šmalc, V., Korbar, M., Mestrovic, B., & Buzina, R. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90061-6 · Cited by 71
Mathew, S., Law, A. J., Lipska, B. K., Dávila‐García, M. I., Zamora, E. D., Mitkus, S. N., Vakkalanka, R., Straub, R. E., Weinberger, D. R., Kleinman, J. E., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm253 · Cited by 71
The possible pathophysiological role of plasma nitric oxide and adrenomedullin in schizophrenia
Zoroğlu, S. S., Herken, H., Yürekli, M., Uz, E., Tutkun, H., SAVAS, H. A., Bağcı, C., Özen, M. E., Cengiz, B., Çakmak, E. A., et al. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00014-6 · Cited by 70
Expression of nNOS and soluble guanylate cyclase in schizophrenic brain
Baba, H., Suzuki, T., Arai, H., & Emson, P. C. (2004) · Neuroreport · doi:10.1097/00001756-200403220-00020 · Cited by 70
Zhang, X., Zhou, D. F., Su, J. M., & Zhang, P. Y. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00015 · Cited by 70
Imbalanced free radicals and antioxidant defense systems in schizophrenia: A comparative study
Li, H.-C., Chen, Q., Ma, Y., & Zhou, J.-F. (2006) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.2006.b0981 · Cited by 68
Lipid peroxidation and homocysteine induced toxicity
Jones, B. G., Rose, F. A., & Tudball, N. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90046-9 · Cited by 68
Kim, E., Park, D.-W., Choi, S.-H., Kim, J., & Cho, H.-S. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31816777f7 · Cited by 68
Genetic Association Studies of Antioxidant Pathway Genes and Schizophrenia
Chowdari, K. V., Bamne, M. N., & Nimgaonkar, V. L. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3508 · Cited by 66
Maxeiner, H. G., Rojewski, M., Schmitt, A., Tumani, H., Bechter, K., & Schmitt, M. W. (2008) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2008.08.003 · Cited by 66
The role of gender in studies of ventricle enlargement in schizophrenia: a predominantly male effect
Flaum, M., Arndt, S. V., & Andreasen, N. C. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.10.1327 · Cited by 65
Cammer, W., & Zhang, H. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00045-4 · Cited by 65
Isoprostenes as indicators of oxidative stress in schizophrenia
Dietrich‐Muszalska, A., & Olas, B. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701361263 · Cited by 62
Neuronal Nitric Oxide Synthase Expression in Developing and Adult Human CNS
Downen, M., Zhao, M. L., Lee, P. C., et al. (1999) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199901000-00002 · Cited by 62
Gysin, R., Kraftsik, R., Boulat, O., Bovet, P., Conus, P., Comte-Krieger, E., Polari, A. R., Steullet, P., Preisig, M., Bellier-Teichmann, T., et al. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3463 · Cited by 62
T-lymphocyte subpopulations in schizophrenic patients
Henneberg, A. E., Riedl, B., Dumke, H. O., & Kornhuber, H. H. (1990) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf01735051 · Cited by 62
The Effect of Risperidone Treatment on Superoxide Dismutase in Schizophrenia
Zhang, X., Zhou, D. F., Cao, L. Y., Zhang, P. Y., Wu, G. Y., & Shen, Y. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00004 · Cited by 61
Lee, B.-H., & Kim, Y. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.06.005 · Cited by 60
Ivezić, S. Š., & John, N. (2009) · PubMed · Cited by 60
Perl, O., Ilani, T., Strous, R. D., Lapidus, R., & Fuchs, S. (2003) · The FASEB Journal · doi:10.1096/fj.03-0104fje · Cited by 59
Saadat, M., Mobayen, F., & Farrashbandi, H. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.03.024 · Cited by 59
Carpenter, W. T. (1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.3.327 · Cited by 59
Iron, metalloenzymes and cytotoxic reactions.
Nappi, A. J., & Vass, E. (2000) · PubMed · Cited by 56
Klamer, D., Engel, J. A., & Svensson, L. (2001) · Psychopharmacology · doi:10.1007/s002130100783 · Cited by 54
Klamer, D., Engel, J. A., & Svensson, L. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.09.042 · Cited by 53
Redox Control of Protein Degradation
Lockwood, T. D. (2000) · Antioxidants and Redox Signaling · doi:10.1089/ars.2000.2.4-851 · Cited by 50
Shutara, Y., Koga, Y., Fujita, K., Takeuchi, H., Mochida, M., & Takemasa, K. (1996) · Brain Topography · doi:10.1007/bf01184786 · Cited by 50
Plasma nitrate levels in deficit versus non-deficit forms of schizophrenia
Suzuki, E., Nakaki, T., Nakamura, M., & Miyaoka, H. (2003) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0335 · Cited by 49
Iron, copper, zinc, magnesium, and calcium in postmortem brain tissue from schizophrenic patients
Kornhuber, J., Lange, K. W., Kruzik, P., Rausch, W., Gabriel, E., Jellinger, K. A., & Riederer, P. F. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90059-0 · Cited by 48
New model of glutathione deficit during development: Effect on lipid peroxidation in the rat brain
Rougemont, M., Kim, Q., & Castagné, V. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10439 · Cited by 48
Hashimoto, T., Hashimoto, K., Matsuzawa, D., Shimizu, E., Sekine, Y., Inada, T., Ozaki, N., Iwata, N., Harano, M., Komiyama, T., et al. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30164 · Cited by 48
Blockade of glutamate excitotoxicity and its clinical applications
Hirose, K., & Chan, P. H. (1993) · Neurochemical Research · doi:10.1007/bf00967252 · Cited by 45
Antioxidant Therapeutics for Schizophrenia
Reddy, R. D., & Reddy, R. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3571 · Cited by 44
Bernstein, H., Krell, D., Braunewell, K., Baumann, B., Gundelfinger, E. D., Diekmann, S., Dános, P., & Bogerts, B. (2001) · Journal of Neurocytology · doi:10.1023/a:1016520932139 · Cited by 41
Serum iron levels in schizophrenic patients with or without akathisia
Kuloğlu, M., Atmaca, M., Üstündağ, B., Canatan, H., Geçici, Ö., & Tezcan, E. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00073-1 · Cited by 41
Methods for depleting brain glutathione
Masukawa, T., Sai, M., & Tochino, Y. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90266-x · Cited by 41
Nakano, Y., Yoshimura, R., Nakano, H., Ikenouchi, A., Hori, H., Umene‐Nakano, W., Ueda, N., & Nakamura, J. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1102 · Cited by 41
Cui, H., Nishiguchi, N., Yanagi, M., Fukutake, M., Mouri, K., Kitamura, N., Hashimoto, T., Shirakawa, O., & Hishimoto, A. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.003 · Cited by 39
Schwartz, R. D., Wagner, J. P., Yu, X., et al. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62030916.x · Cited by 38
Mazzarello, V., Cecchini, A., Fenu, G., Rassu, M., Dessy, L. A., Lorettu, L., & Montella, A. (2004) · PubMed · Cited by 31
Tang, W., Huang, K., Tang, R., Zhou, G., Fang, C., Zhang, J., Du, L., Feng, G., He, L., & Shi, Y. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008924 · Cited by 30
DeKosky, S. T., Abrahamson, E. E., Taffe, K. M., Dixon, C. E., Kochanek, P. M., & Ikonomović, M. D. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02575.x · Cited by 28
Cammer, W. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(02)00830-4 · Cited by 27
A postmortem quantitative study of iron in the globus pallidus of schizophrenic patients
Casanova, M. F., Waldman, I. N., & Kleinman, J. E. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90644-h · Cited by 25
Janáky, R., Varga, V., Oja, S. S., & Saransaari, P. (1994) · Neurochemistry International · doi:10.1016/0197-0186(94)90010-8 · Cited by 23
Apoptosis of oligodendrocytes in secondary cultures from neonatal rat brains
Cammer, W. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00392-0 · Cited by 22
Wass, C., Svensson, L., Fejgin, K., Pålsson, E., Archer, T., Engel, J. A., & Klamer, D. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.01.011 · Cited by 22
Okumura, T., Okochi, T., Kishi, T., Ikeda, M., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., Kawashima, K., Tsunoka, T., Ujike, H., et al. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8068-z · Cited by 21
Gysin, R., Riederer, I. M., Cuénod, M., Kim, Q., & Riederer, B. M. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.10.015 · Cited by 20
Is it time to reassess alpha lipoic acid and niacinamide therapy in schizophrenia?
Seybolt, S. E. J. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.07.034 · Cited by 19
Dean, O. M., Bush, A. I., Berk, M., Copolov, D., & van den Buuse, M. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.08.013 · Cited by 16
Ohyama, K., Sano, T., & Toyoda, H. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.1750 · Cited by 15
Iwamoto, K., Ueda, J., Bundo, M., Nakano, Y., & Kato, T. (2008) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2007.01786.x · Cited by 12
Higher Order Chromatin Degradation: Implications for Neurodegeneration
Konat, G. W. (2002) · Neurochemical Research · doi:10.1023/a:1021688119574 · Cited by 9
Cited by
Role of oxidative stress in depression
Bhatt, S., Nagappa, A. N., & Patil, C. R. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.05.001 · Cited by 821
Meta-analysis of oxidative stress in schizophrenia.
Flatow, J., Buckley, P., & Miller, B. J. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.018 · Cited by 491
Free radicals, antioxidant defense systems, and schizophrenia
Wu, J. Q., Kosten, T. R., & Zhang, X. Y. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.02.015 · Cited by 424
A Brief Overview on Antioxidant Activity Determination of Silver Nanoparticles
Bedlovičová, Z., Strapáč, I., Baláž, M., & Salayová, A. (2020) · Molecules · doi:10.3390/molecules25143191 · Cited by 387
Clusterin in Alzheimer’s Disease: Mechanisms, Genetics, and Lessons From Other Pathologies
Foster, E. M., Dangla-Valls, A., Lovestone, S., Ribe, E. M., & Buckley, N. J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00164 · Cited by 381
“, 2015), which is associated with schizophrenia pathophysiology (Bitanihirwe and Woo, 2011).”
Background
Metadata
- Authors
- Bitanihirwe, B. K. Y., & Woo, T.-U. W.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 35
- Issue
- 3
- Pages
- 878-893
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W1965707086
- Cited by
- 472
- References
- 322
- FWCI
- 14.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.